A study found people who took vitamin D supplements were less likely to develop dementia. But experts said other factors may have been the reason for the reduced risk.

Researchers at the University of Kentucky are in on a clinical trial on the use of medical cannabis for late-stage dementia patients. As research continues, those involved say this would be a game ...

BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

Repurposing existing drugs, including antibiotics, antivirals, and vaccines, may offer a promising strategy for combating ...

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Broad classes of drugs, including antibiotics, antivirals, vaccines, anti-inflammatories and antihypertensives, were ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...